MYEF2 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 3.90554255602638E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.49959999762706E-08 |
Normal-vs-Stage2 |
9.237000E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
3.175800E-03 |
Stage1-vs-Stage2 |
2.823600E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
4.954000E-02 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
4.599600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.144300210143E-10 |
Normal-vs-AfricanAmerican |
1.520040E-01 |
Normal-vs-Asian |
1.684420E-01 |
Caucasian-vs-AfricanAmerican |
4.705600E-01 |
Caucasian-vs-Asian |
9.790600E-01 |
AfricanAmerican-vs-Asian |
6.508000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.69009999998016E-06 |
Normal-vs-Female |
2.510500000108E-07 |
Male-vs-Female |
9.286000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
8.648400E-04 |
Normal-vs-Extreme_Weight |
4.21250000004481E-06 |
Normal-vs-Obese |
6.400700E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
7.373000E-01 |
Normal_Weight-vs-Obese |
1.415640E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.868400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.824000E-01 |
Normal-vs-Age(41-60Yrs) |
4.06480000003651E-06 |
Normal-vs-Age(61-80Yrs) |
6.93000000051569E-07 |
Normal-vs-Age(81-100Yrs) |
4.775400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.274200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.591800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.476800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.810000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.906000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.731200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
9.235000E-01 |
Normal-vs-Grade 3 |
8.492400E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
4.255400E-01 |
Grade 2-vs-Grade 4 |
9.235000E-01 |
Grade 3-vs-Grade 4 |
8.492400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.26030000166833E-09 |
Normal-vs-N1 |
1.496220E-02 |
N0-vs-N1 |
5.380200E-02 |
|
|